Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 22Observational 2

Sponsor

Conditions

Breast Neoplasms 112Neoplasms 73Carcinoma, Non-Small-Cell Lung 36Carcinoma, Renal Cell 35Prostatic Neoplasms 34Colorectal Neoplasms 34Lung Neoplasms 31Melanoma 17Multiple Myeloma 16Ovarian Neoplasms 13Urinary Bladder Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 11Lymphoma, Follicular 11Colonic Neoplasms 11Stomach Neoplasms 10Lymphoma 10Kidney Neoplasms 10Hematologic Neoplasms 10Rectal Neoplasms 9Arthritis, Rheumatoid 9Recurrence 8Papillomavirus Infections 8Leukemia, Myeloid, Acute 8Carcinoma, Hepatocellular 8Pancreatic Neoplasms 7Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7COVID-19 7Leukemia, Lymphocytic, Chronic, B-Cell 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Has results × Psoriasis × Clear all
NCT05796245 2025-06-04

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Pfizer

Completed
2,207 enrolled 10 charts

Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Psoriasis

NCT01126619 2012-10-25

A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis

Abbott

Completed
103 enrolled 18 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡